phenyl acetate has been researched along with Ventricular Dysfunction, Left in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, N; Du, XJ; Huynh, K; Kemp-Harper, BK; Kiriazis, H; Qin, C; Ritchie, RH; Rosli, S; Wong, YG | 1 |
| Frøkiær, J; Hansen, E; Hansson, NH; Harms, HJ; Jakobsen, S; Kim, WY; Sørensen, J; Tolbod, L; Wiggers, H; Zaremba, T | 1 |
| Chiba, S; Iwano, H; Katoh, C; Manabe, O; Matsui, Y; Naya, M; Tamaki, N; Tsutsui, H; Yamada, S; Yoshinaga, K | 1 |
| Araki, T; Higuchi, T; Ikeda, M; Namura, M; Taki, J; Tsuchiya, T; Yoshida, N | 1 |
| Burchert, W; Lichtlen, PR; Meyer, GJ; van den Hoff, J; Weinhardt, R; Wolpers, HG | 1 |
| Beanlands, RS; Coates, G; deKemp, R; Fallen, E; Firnau, G; Gordon, E; Nahmias, C | 1 |
1 trial(s) available for phenyl acetate and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: A double-blind, placebo-controlled, positron-emission tomography study.
Topics: Acetates; Adrenergic beta-Antagonists; Aged; Blood Pressure; Carbon Radioisotopes; Cardiomyopathies; Double-Blind Method; Echocardiography; Female; Heart Rate; Humans; Male; Metoprolol; Myocardial Ischemia; Oxidation-Reduction; Radiography; Receptors, Adrenergic, beta-1; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2000 |
5 other study(ies) available for phenyl acetate and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
Topics: Acetates; Animals; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diastole; Dose-Response Relationship, Drug; Hypertrophy, Left Ventricular; Male; Mice; Myocytes, Cardiac; Nitric Oxide Donors; Nitroso Compounds; Superoxides; Vasodilation; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Evaluation of ECG-gated [(11)C]acetate PET for measuring left ventricular volumes, mass, and myocardial external efficiency.
Topics: Acetates; Carbon Radioisotopes; Cardiac Imaging Techniques; Cardiac-Gated Imaging Techniques; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Organ Size; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Ventricular Dysfunction, Left | 2016 |
Myocardial oxidative metabolism is increased due to haemodynamic overload in patients with aortic valve stenosis: assessment using 11C-acetate positron emission tomography.
Topics: Acetates; Aged; Aortic Valve Stenosis; Carbon; Female; Humans; Male; Metabolic Clearance Rate; Oxidation-Reduction; Positron-Emission Tomography; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2010 |
Changes in myocardial oxidative metabolism after biventricular pacing as evaluated by [11C]acetate positron emission tomography.
Topics: Acetates; Aged; Carbon; Cardiac Pacing, Artificial; Female; Heart; Heart Failure; Humans; Myocardium; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction.
Topics: Acetates; Aged; Carbon Isotopes; Coronary Circulation; Differential Threshold; Heart; Humans; Middle Aged; Myocardial Infarction; Myocardium; Predictive Value of Tests; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |